ESB
Essex Savings Bank’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $741K | Sell |
10,735
-857
| -7% | -$59.2K | 0.18% | 113 |
|
|
2025
Q1 | $805K | Buy |
11,592
+1,956
| +20% | +$136K | 0.2% | 108 |
|
|
2024
Q4 | $829K | Buy |
9,636
+715
| +8% | +$61.5K | 0.21% | 101 |
|
|
2024
Q3 | $1.06M | Buy |
8,921
+5
| +0.1% | +$595 | 0.27% | 86 |
|
|
2024
Q2 | $1.27M | Buy |
8,916
+486
| +6% | +$69.4K | 0.34% | 70 |
|
|
2024
Q1 | $872K | Hold |
8,430
| – | – | 0.25% | 97 |
|
|
2023
Q4 | $872K | Buy |
8,430
+946
| +13% | +$97.9K | 0.25% | 97 |
|
|
2023
Q3 | $681K | Buy |
7,484
+3,746
| +100% | +$341K | 0.23% | 95 |
|
|
2023
Q2 | $605K | Buy |
3,738
+13
| +0.3% | +$2.1K | 0.2% | 106 |
|
|
2023
Q1 | $593K | Buy |
3,725
+32
| +0.9% | +$5.09K | 0.21% | 105 |
|
|
2022
Q4 | $500K | Buy |
3,693
+6
| +0.2% | +$812 | 0.18% | 118 |
|
|
2022
Q3 | $367K | Sell |
3,687
-405
| -10% | -$40.3K | 0.15% | 139 |
|
|
2022
Q2 | $456K | Buy |
4,092
+442
| +12% | +$49.3K | 0.17% | 121 |
|
|
2022
Q1 | $406K | Hold |
3,650
| – | – | 0.13% | 138 |
|
|
2021
Q4 | $409K | Hold |
3,650
| – | – | 0.14% | 140 |
|
|
2021
Q3 | $365K | Hold |
3,650
| – | – | 0.13% | 150 |
|
|
2021
Q2 | $288K | Hold |
3,650
| – | – | 0.11% | 164 |
|
|
2021
Q1 | $260K | Hold |
3,650
| – | – | 0.11% | 164 |
|
|
2020
Q4 | $254K | Hold |
3,650
| – | – | 0.11% | 163 |
|
|
2020
Q3 | $253K | Hold |
3,650
| – | – | 0.12% | 161 |
|
|
2020
Q2 | $239K | Sell |
3,650
-680
| -16% | -$44.5K | 0.14% | 148 |
|
|
2020
Q1 | $261K | Sell |
4,330
-33
| -0.8% | -$1.99K | 0.19% | 122 |
|
|
2019
Q4 | $253K | Hold |
4,363
| – | – | 0.13% | 155 |
|
|
2019
Q3 | $226K | Sell |
4,363
-150
| -3% | -$7.77K | 0.12% | 160 |
|
|
2019
Q2 | $230K | Sell |
4,513
-31,756
| -88% | -$1.62M | 0.08% | 211 |
|
|
2019
Q1 | $1.9M | Hold |
36,269
| – | – | 1.08% | 15 |
|
|
2018
Q4 | $1.67M | Buy |
+36,269
| New | +$1.67M | 1.05% | 17 |
|